ACADIA Pharmaceuticals to Present at BIO InvestorForum 2005 on October 20, 2005
SAN DIEGO, Oct 13, 2005 /PRNewswire-FirstCall via COMTEX News Network/ — ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that Uli Hacksell, Ph.D., Chief Executive Officer, will present at BIO InvestorForum 2005 on Thursday, October 20, 2005, at 12:00 p.m. Pacific Time at The Palace Hotel in San Francisco.
A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through November 3, 2005.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has four drug programs in clinical development as well as a portfolio of preclinical and discovery assets directed at large unmet medical needs, including schizophrenia, Parkinson’s disease, neuropathic pain, and glaucoma. Using its proprietary drug discovery platform, ACADIA has discovered all of the drug candidates in its product pipeline. ACADIA’s corporate headquarters is located in San Diego, California, and it maintains research and development operations in both San Diego and Malmo, Sweden.
ACADIA Pharmaceuticals Inc.
Lisa Barthelemy, Director, Investor Relations
Thomas H. Aasen, Vice President and Chief Financial Officer
SOURCE ACADIA Pharmaceuticals Inc.